Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer

Objectives. The aim of our study was to examine serum anti-Müllerian hormone (AMH) concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, (FIGO) stage, grading, and overall 5-year survival. Material and Methods. We enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Walentowicz, Pawel, Sadlecki, Pawel, Krintus, Magdalena, Sypniewska, Grazyna, Mankowska-Cyl, Aneta, Grabiec, Marek, Walentowicz-Sadlecka, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745840/
https://www.ncbi.nlm.nih.gov/pubmed/23983687
http://dx.doi.org/10.1155/2013/517239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745840/
https://www.ncbi.nlm.nih.gov/pubmed/23983687
http://dx.doi.org/10.1155/2013/517239

Ejemplares similares